We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Medgenics(Regs) | LSE:MEDG | London | Ordinary Share | COM SHS USD0.0001 (REGS) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 302.50 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
Medgenics, Inc.
('Medgenics' or the 'Company')
Total Voting Rights
30 June 2008
Following the block listing interim review on 4 June 2008, and in accordance
with the Financial Services Authority's Disclosure and Transparency Rules, the
Company hereby announces that it has 106,698,096 common shares of US$0.0001 each
in issue, each share carrying the right to one vote. The Company does not hold
any common shares in Treasury.
The above figure of 106,698,096 common shares may be used by shareholders in the
Company as the denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their interest in,
the share capital of the Company under the Financial Services Authority's
Disclosure and Transparency Rules.
For further information, contact:
Medgenics, Inc. +972 4 958 8555
Dr. Andrew L. Pearlman
Blomfield Corporate Finance +44 207 489 4500
James Pinner or
Alan MacKenzie
SVS Securities plc +44 207 638 5600
Peter Manfield or
Ian Callaway
Citigate Dewe Rogerson +44 207 638 9571
Jonathan Shillington or
Mark Swallow or
Chris Gardner
1 Year Medgenics(Regs) Chart |
1 Month Medgenics(Regs) Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
